Evidence map›Paper›PMID 35607393›Full record

ArticleJournal of healthcare engineering2022

Cervical Lesion Classification Method Based on Cross-Validation Decision Fusion Method of Vision Transformer and DenseNet.

Ping Li, Xiaoxia Wang, Peizhong Liu, Tianxiang Xu, Pengming Sun, Binhua Dong, Huifeng Xue

Abstract read
In one paragraph

Article in Journal of healthcare engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ping LiDepartment of Gynecology and Obstetrics, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou 362000, Fujian, China.ORCID 0000-0002-5598-1139
Xiaoxia WangSchool of Medicine, Huaqiao University, Quanzhou 362000, Fujian, China.ORCID 0000-0002-7131-1792
Peizhong LiuSchool of Medicine, Huaqiao University, Quanzhou 362000, Fujian, China.ORCID 0000-0003-2619-1629
Tianxiang XuCollege of Engineering, Huaqiao University, Quanzhou 362000, Fujian, China.ORCID 0000-0003-0759-6866
Pengming SunFujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou 350001, Fujian, China.ORCID 0000-0002-5072-6091
Binhua DongFujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou 350001, Fujian, China.ORCID 0000-0002-5086-0696
Huifeng XueFujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou 350001, Fujian, China.ORCID 0000-0001-8338-0296

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: In order to better adapt to clinical applications, this paper proposes a cross-validation decision-making fusion method of Vision Transformer and DenseNet161. Methods: The dataset is the most critical acetic acid image for clinical diagnosis, and the SR areas are processed by a specific method. Then, the Vision Transformer and DenseNet161 models are trained by the fivefold cross-validation method, and the fivefold prediction results corresponding to the two models are fused by different weights. Finally, the five fused results are averaged to obtain the category with the highest probability. Results: The results show that the fusion method in this paper reaches an accuracy rate of 68% for the four classifications of cervical lesions. Conclusions: It is more suitable for clinical environments, effectively reducing the missed detection rate and ensuring the life and health of patients.

Indexed as

Electric Power SuppliesResearch DesignHumans

Identifiers

PMID35607393
PMCPMC9124126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.